Multiple early factors anticipate post-acute COVID-19 sequelae

Abstract

Post-acute sequelae of COVID-19 (PASC) represent an emerging global crisis. However, quantifiable risk factors for PASC and their biological associations are poorly resolved. We executed a deep multi-omic, longitudinal investigation of 309 COVID-19 patients from initial diagnosis to convalescence (2–3 months later), integrated with clinical data and patient-reported symptoms. We resolved four PASC-anticipating risk factors at the time of initial COVID-19 diagnosis: type 2 diabetes, SARS-CoV-2 RNAemia, Epstein-Barr virus viremia, and specific auto-antibodies. In patients with gastrointestinal PASC, SARS-CoV-2-specific and CMV-specific CD8 + T cells exhibited unique dynamics during recovery from COVID-19. Analysis of symptom-associated immunological signatures revealed coordinated immunity polarization into four endotypes, exhibiting divergent acute severity and PASC. We find that immunological associations between PASC factors diminish over time, leading to distinct convalescent immune states. Detectability of most PASC factors at COVID-19 diagnosis emphasizes the importance of early disease measurements for understanding emergent chronic conditions and suggests PASC treatment strategies.

Cited by papers we hold 19

• Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2 · 2024
  No notice
• Single-cell sequencing to multi-omics: technologies and applications · 2024
  No notice
• Distinguishing features of long COVID identified through immune profiling · 2023
  No notice
• Racial/Ethnic Disparities in Post-acute Sequelae of SARS-CoV-2 Infection in New York: an EHR-Based Cohort Study from the RECOVER Program · 2023
  No notice
• Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC) · 2023
  No notice
• Chronic viral coinfections differentially affect the likelihood of developing long COVID · 2023
  No notice
• Viral persistence, reactivation, and mechanisms of long COVID · 2023
  No notice
• Pathogenesis Underlying Neurological Manifestations of Long COVID Syndrome and Potential Therapeutics · 2023
  No notice
• ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature · 2023
  No notice
• Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study · 2023
  Corrected
• Persistent serum protein signatures define an inflammatory subcategory of long COVID · 2023
  No notice
• Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID · 2023
  No notice
• Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system · 2022
  No notice
• Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection With Risk of Post–COVID-19 Conditions · 2022
  No notice
• SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2 · 2022
  No notice
• Long COVID and its Management · 2022
  No notice
• Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes · 2022
  No notice
• Autoimmunity is a hallmark of post-COVID syndrome · 2022
  No notice
• SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery · 2022
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.